Want to see PGNY full AI Analyst Report?
Operating Expense Breakdown
Shows how Progyny allocates spending across sales and marketing, technology, and general administration, helping investors judge whether the company is investing efficiently to grow members and move toward sustainable margins.Progyny’s cost base has shifted from gradual growth into a G&A‑led acceleration: S&M climbed steadily as the company pushed for growth, but G&A jumped in 2022 and then surged again in late‑2025, materially outpacing S&M. That pattern suggests non-operational or corporate expenses (e.g., one‑time charges, stock‑based comp, M&A or legal costs) are eroding operating leverage; investors should demand management disclosure that ties these spikes to revenue benefits or one-offs, otherwise profitability and cash flow will remain under pressure.
Date | Sales and Marketing | General and Administrative |
|---|---|---|
Jun 30, 2026 | $18.07M | $31.22M |
Mar 31, 2026 | $16.88M | $30.81M |
Dec 31, 2025 | $17.99M | $43.67M |
Sep 30, 2025 | $17.93M | $33.37M |
Jun 30, 2025 | $18.41M | $36.21M |
Mar 31, 2025 | $17.79M | $33.84M |
Dec 31, 2024 | $15.62M | $32.03M |
Sep 30, 2024 | $16.46M | $30.33M |
Jun 30, 2024 | $16.42M | $31.17M |
Mar 31, 2024 | $15.45M | $28.43M |